Target intelligence / Profile preview

Monooxygenase DBH-like 2 pseudogene (MOXD2P)

Target
MOXD2P
Molecular classification
Pseudogene, Other (Putative oxidoreductase)
01

Overview

Monooxygenase DBH-like 2 pseudogene (MOXD2P) is a human gene classified as a pseudogene, meaning it appears related to functional genes but lacks crucial exons and regulatory sequences required for expression of a functional protein product. It is predicted by database annotation to enable copper ion binding and dopamine beta-monooxygenase activity and may be involved in dopamine catabolic processes, norepinephrine biosynthetic processes, and octopamine biosynthetic processes. However, there is no experimental evidence confirming any biological activity, physiological function, or disease association for MOXD2P. It is not considered a therapeutic target in pharmacology, and no known drugs, biomarkers, or disease links have been characterized for this gene.

Other names
MOXD2DBH-like monooxygenase protein 2 pseudogeneDopamine-beta-hydroxylase-like pseudogenePutative DBH-like monooxygenase protein 2Monooxygenase, DBH-like 2 pseudogeneDBH-like monooxygenase protein 2EC 1.14.17.-
02

Mechanism of action

Null

Beyond the preview

Go deeper on Monooxygenase DBH-like 2 pseudogene (MOXD2P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Monooxygenase DBH-like 2 pseudogene (MOXD2P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call